Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma

Phase 1

Completed

Conditions: Glioma
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma
Anaplastic Oligoastrocytoma
Astrocytoma, Grade III
Glioblastoma Multiforme
Astrocytoma, Grade IV
Brain Cancer

Interventions: Biological: Neural stem cells loaded with an oncolytic adenovirus

First Posted Date: 2017-03-07

Last Posted Date: 2023-01-20

Lead Sponsor: Northwestern University

Target Recruit Count: 12

Registration Number: NCT03072134

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸
City of Hope, Duarte, California, United States

Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Phase 2

Terminated

Conditions: Breast Carcinoma Metastatic in the Bone
Estrogen Receptor Positive
Circulating Tumor Cell Count
Stage IV Breast Cancer
HER2/Neu Negative
Progesterone Receptor Positive

Interventions: Biological: Denosumab
Other: Laboratory Biomarker Analysis

First Posted Date: 2017-03-03

Last Posted Date: 2018-11-20

Lead Sponsor: Northwestern University

Target Recruit Count: 1

Registration Number: NCT03070002

Locations: 🇺🇸
Northwestern University- Lake Forest Hospital, Lake Forest, Illinois, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

Evaluation of a Hospital Discharge Clinic to Improve Care Coordination and Reduce Rehospitalization in Low Income Adults

Not Applicable

Completed

Conditions: Patient Readmission

Interventions: Other: Federally Qualified Health Center
Other: Northwestern Follow Up Care Coordination

First Posted Date: 2017-02-28

Last Posted Date: 2019-06-25

Lead Sponsor: Northwestern University

Target Recruit Count: 654

Registration Number: NCT03066492

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

Photodynamic Therapy Incubation Times for Actinic Keratosis

Not Applicable

Active, not recruiting

Conditions: Actinic Keratoses

Interventions: Drug: ALA (5-aminolevulinic acid)
Device: Blue light therapy

First Posted Date: 2017-02-28

Last Posted Date: 2024-02-05

Lead Sponsor: Northwestern University

Target Recruit Count: 60

Registration Number: NCT03066843

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States

Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma

Phase 1

Completed

Conditions: Refractory Mantle Cell Lymphoma
Advanced Solid Neoplasm
Aggressive Non-Hodgkin Lymphoma
Recurrent Solid Neoplasm
T-Cell Non-Hodgkin Lymphoma
Unresectable Solid Neoplasm

Interventions: Other: Laboratory Biomarker Analysis
Biological: Nivolumab
Other: Pharmacological Study
Drug: Veliparib

First Posted Date: 2017-02-23

Last Posted Date: 2024-06-12

Lead Sponsor: Northwestern University

Target Recruit Count: 15

Registration Number: NCT03061188

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia

Not Applicable

Active, not recruiting

Conditions: Thrombocytopenia
Cirrhosis

Interventions: Device: TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.

First Posted Date: 2017-02-23

Last Posted Date: 2024-05-23

Lead Sponsor: Northwestern University

Target Recruit Count: 20

Registration Number: NCT03059030

Locations: 🇺🇸
Northwestern University/Northwestern Memorial Hospital, Chicago, Illinois, United States

Promoting Early Detection of Melanoma During the Mammography Experience

Not Applicable

Completed

Conditions: Melanoma (Skin Cancer)

Interventions: Behavioral: Improve awareness of checking moles
Other: Comparator

First Posted Date: 2017-02-20

Last Posted Date: 2017-10-09

Lead Sponsor: Northwestern University

Target Recruit Count: 560

Registration Number: NCT03057327

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

PDL and Fractional Photothermolysis for Postsurgical Scars

Not Applicable

Conditions: Scar

Interventions: Device: PDL (Pulsed Dye Laser)
Device: Fractional Photothermolysis Laser

First Posted Date: 2017-02-20

Last Posted Date: 2024-02-05

Lead Sponsor: Northwestern University

Target Recruit Count: 150

Registration Number: NCT03057964

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States

Improve PAD PERformance With METformin

Phase 3

Recruiting

Conditions: Peripheral Artery Disease

Interventions: Drug: Placebo
Drug: Metformin

First Posted Date: 2017-02-15

Last Posted Date: 2023-05-24

Lead Sponsor: Northwestern University

Target Recruit Count: 212

Registration Number: NCT03054519

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Ochsner Medical Center, New Orleans, Louisiana, United States

and more 2 locations

Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres

Not Applicable

Completed

Conditions: Benign Prostatic Hyperplasia (BPH)

Interventions: Device: Prostate Artery Embolization

First Posted Date: 2017-02-14

Last Posted Date: 2023-10-10

Lead Sponsor: Northwestern University

Target Recruit Count: 28

Registration Number: NCT03052049

Locations: 🇺🇸
Northwestern, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy